[Therapy of the primary symptom anxiety in neuroses, abnormal experience reactions, neuro-vegative psychosomatic disorders and depressions].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001008:Anxiety Disorders / Q000188:drug therapy*; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D002648:Child; D003863:Depression / Q000188:drug therapy*; D004402:Dysautonomia, Familial / Q000188:drug therapy; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use
D001552:Benzazepines; D014149:Tranquilizing Agents
Die Behandlung des Zielsymptoms Angst bei Neurosen, abnormen Erlebnisreaktionen, neuro-vegetativen psychosomatischen Störungen und Depressionen.